Identification of Vulnerability Factors in the Course of Pemphigus Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-20

Study Completion Date

2017-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The bullous pemphigoid treatment is based on corticosteroids continued for several years. Pemphigus causes some patients a psychological impact and sometimes major vulnerability that can occur not only at diagnosis but also at later stages of disease progression. Our hypothesis is that these episodes of vulnerability may be under four kinds of factors that may be connected to the plurality of the history of these patients, and the resources they can mobilize throughout this experience, generating inequality in management and "work" around the disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid

NCT03272958

Bullous Pemphigoid

COMPLETED

Autoimmune Blistering Diseases Study

NCT02753777

Pemphigus Vulgaris Pemphigus Foliaceus Bullous Pemphigoid

RECRUITING

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

NCT03636763

Bullous Pemphigoid

UNKNOWN

Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.

NCT07188402

Bullous Pemphigoid (BP)

COMPLETED

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

NCT06167408

Pemphigus Vulgaris

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The originality of the project lies in its multidisciplinary approach (dermatology, psychology, sociology). No such study has yet been carried out in the pemphigus who has been the subject of a very small number of works in sociology or psychology. The only studies are studies of quality of life with no longitudinal follow-up. The perspective of qualitative and quantitative data, sociological and psychological approaches, should allow more innovative and adapted to the medico-social and psychological care of patients with pemphigus approaches. The purpose of this study is to identify the determinants leading to moments of vulnerability in the course of patients with pemphigus in order to be able to offer preventive or corrective actions to improve the experience of the disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pemphigus Dermatological Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

prevalent cases

40 prevalent cases correspond to patients with known pemphigus. Emphasis will be on included patients at different times of the course of their disease.

8 incident cases recruited through the center of Rouen and following an intervention program with psychological support and therapeutic education program

Group Type EXPERIMENTAL

psychological support and therapeutic education program

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychological support and therapeutic education program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient major
* Patients with pemphigus vulgaris, diagnosed on a combination of:

1. clinical signs and
2. histological image above basal epithelial detachment with intra acantholysis,
3. direct immunofluorescence showing deposition of Immunoglobulin G and / or C3 to the surface of keratinocytes
* Join a social security scheme
* patient has been informed and have signed consent to participate in the study

Exclusion Criteria

* Person placed under judicial protection,
* Patient without liberty by administrative or judicial decision,
* Patient participating in another trial for the duration of monitoring.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No